SEC CIK 1252523
LIPTAK ROBERT
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| GMEDview stock → | 41,159 | 2016-01-06 |
Position History — GMED
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — GMED
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2019-01-22 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2018-01-22 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2017-01-30 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2016-01-25 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2016-01-06 | Option exercise (derivative) | 15,000 | $0.00 | 0 |
| 2016-01-06 | Option exercise | 15,000 | $15.34 | 41,159 |
| 2016-01-06 | Open-market sale | 15,000 | $27.50 | 26,159 |
| 2016-01-04 | Option exercise (derivative) | 300 | $0.00 | 15,000 |
| 2016-01-04 | Open-market sale | 300 | $27.50 | 26,159 |
| 2016-01-04 | Option exercise | 300 | $15.34 | 26,459 |
| 2015-01-20 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2014-01-23 | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2013-12-06 | Open-market sale | 25,000 | $19.36 | 26,159 |
| 2013-09-03 | J | 7,244,201 | $0.00 | 0 |
| 2013-09-03 | J | 7,244,201 | $0.00 | 0 |
| 2013-09-03 | J | 51,159 | $0.00 | 51,159 |
| 2013-01-30 | Grant / award (derivative) | 7,500 | $0.00 | 7,500 |
| 2012-08-29 | Grant / award (derivative) | 15,300 | $0.00 | 15,300 |
| 2012-08-08 | Conversion (derivative) | 7,444,168 | $0.00 | 0 |
| 2012-08-08 | Open-market sale | 804,232 | $11.16 | 7,244,201 |
| 2012-08-08 | Conversion | 7,444,168 | $0.00 | 8,048,433 |
| 2012-08-08 | Conversion (derivative) | 7,444,168 | $0.00 | 0 |
| 2012-08-08 | Open-market sale | 804,232 | $11.16 | 7,244,201 |
| 2012-08-08 | Conversion | 7,444,168 | $0.00 | 8,048,433 |
| 2012-08-02 | — | — | — | 604,265 |
| 2012-08-02 | — | — | — | 604,265 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.